Clinical Trial Update: Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients. [Phase 2]

View source ↗

Summary

A Phase 2 study of JNJ-18054478 in asthma patients was terminated; the update notes the trial’s status and available safety/efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• JNJ-18054478

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Asthma | Phase 2 | Status: TERMINATED